@article{e12930e00eb54d04bebe2586aac0048c,
title = "Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma",
author = "Claus Bachert and Hellings, {Peter W.} and Joaquim Mullol and Naclerio, {Robert M.} and Jingdong Chao and Nikhil Amin and Annette Grabher and Swanson, {Brian N.} and Hamilton, {Jennifer D.} and Sophie Guillonneau and Christine Taniou and Donghui Zhang and Gianluca Pirozzi and Graham, {Neil M.H.} and Heribert Staudinger and Mannent, {Leda P.} and Asif Khan",
note = "Funding Information: Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals . Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals.Conflicts of interest: C. Bachert is the principal investigator of the study, and serves on the advisory boards of ActoBiotics, ALK, ASIT Biotech, AstraZeneca, Novartis, Sanofi, and Stallergenes. P. W. Hellings serves on the advisory board of Regeneron Pharmaceuticals, Inc. J. Mullol is the member of national and international scientific advisory boards (consulting) of and receives fees for lectures and grants for research projects from ALK-Abell?, Allakos, FAES, Genentech, Glenmark, GSK, Mylan, Menarini, MSD, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, UCB, and Uriach. R. M. Naclerio serves on the advisory board of ActoBiotics, Genentech, Novartis, and Sanofi; and is on the speaker's bureau of Optinose. J. Chao, N. Amin, J. D. Hamilton, and N. M. H. Graham are employees and shareholders of Regeneron Pharmaceuticals, Inc. A. Grabher, S. Guillonneau, D. Zhang, G. Pirozzi, H. Staudinger, L. P. Mannent, and A. Khan are employees of Sanofi and may hold stock and/or stock options in the company. B. N. Swanson is the former Sanofi employee and may hold stock or stock options in the company. C. Taniou is the employee of Altran Technologies.Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals. Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals.Conflicts of interest: C. Bachert is the principal investigator of the study, and serves on the advisory boards of ActoBiotics, ALK, ASIT Biotech, AstraZeneca, Novartis, Sanofi, and Stallergenes. P. W. Hellings serves on the advisory board of Regeneron Pharmaceuticals, Inc. J. Mullol is the member of national and international scientific advisory boards (consulting) of and receives fees for lectures and grants for research projects from ALK-Abell{\'o}, Allakos, FAES, Genentech, Glenmark, GSK, Mylan, Menarini, MSD, Novartis, Regeneron Pharmaceuticals, Sanofi Genzyme, UCB, and Uriach. R. M. Naclerio serves on the advisory board of ActoBiotics, Genentech, Novartis, and Sanofi; and is on the speaker's bureau of Optinose. J. Chao, N. Amin, J. D. Hamilton, and N. M. H. Graham are employees and shareholders of Regeneron Pharmaceuticals, Inc. A. Grabher, S. Guillonneau, D. Zhang, G. Pirozzi, H. Staudinger, L. P. Mannent, and A. Khan are employees of Sanofi and may hold stock and/or stock options in the company. B. N. Swanson is the former Sanofi employee and may hold stock or stock options in the company. C. Taniou is the employee of Altran Technologies.Editorial assistance was provided by Bilge Yoruk, PhD, and Ravi Subramanian, PhD, of Excerpta Medica funded by Sanofi Genzyme and Regeneron Pharmaceuticals. Funding Information: The research was sponsored by Sanofi and Regeneron Pharmaceuticals . ",
year = "2019",
month = sep,
day = "1",
doi = "10.1016/j.jaip.2019.03.023",
language = "English",
volume = "7",
pages = "2447--2449.e2",
journal = "Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
number = "7",
}